carmustine

Italy

Drugs containing this active substance

  • BICNU

    This medicine contains carmustine, an anticancer substance that slows the growth of tumor cells. It is used to treat several types of tumors, including brain tumors, multiple myeloma, Hodgkin's disease, non-Hodgkin lymphomas, gastrointestinal tract tumors, and malignant melanoma. It is also used as a preparation before a stem cell transplant.

    Form: powder and solvent for concentrate for solution for infusion

    Active substance Dosage
    carmustine -

    ATC: L01AD01

    Manufacturer: TILLOMED ITALIA SRL

  • This medicinal product is an antineoplastic agent used to treat several types of tumors, including brain tumors, multiple myeloma, Hodgkin's disease, non-Hodgkin lymphomas, and certain gastrointestinal tract tumors. It is also used as a preparation before a stem cell transplant.

    Form: powder and solvent for concentrate for solution for infusion

    Active substance Dosage
    carmustine -

    ATC: L01AD01

    Manufacturer: Eugia Pharma (Malta) Limited

  • It is an antitumoral drug used in adults to treat various types of tumors, including brain tumors, lymphomas (Hodgkin and non-Hodgkin), gastrointestinal tract tumors, malignant melanoma, and as preparation before a stem cell transplant in certain blood diseases.

    Form: solution for infusion, powder and solvent for preparation

    Active substance Dosage
    carmustine -

    ATC: L01AD01

    Manufacturer: MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH

  • This drug is an antineoplastic agent used to treat several types of malignant tumors, including brain tumors (such as glioblastoma and astrocytoma), brain metastases, lymphomas (Hodgkin and non-Hodgkin), multiple myeloma, and as preparation for stem cell transplantation in certain blood diseases.

    Form: powder and solvent for concentrate for solution for infusion

    Active substance Dosage
    carmustine -

    ATC: L01AD01

    Manufacturer: WAYMADE B.V.

  • It is used to treat adult patients with brain tumors (such as high-grade glioma or glioblastoma multiforme) as an adjunct to surgery and radiotherapy, helping to combat the proliferation of tumor cells and prolonging survival.

    Form: implant

    Active substance Dosage
    carmustine -

    ATC: L01AD01

    Manufacturer: CLINIGEN HEALTHCARE B.V.